The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 35 | — | 20.1x | Near average | |
Growth | 87 | — | 5.6% | Above average | |
Quality | 13 | -43.3% | 7.6% | Below average | |
Safety | 51 | 4.5x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 17 | — | — | Below average | |
Sentiment | 48 | — | — | Near average |
Microbot Medical Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Microbot Medical Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The stock has undergone a sharp downward revision in its price target by analysts over the past 30 days, with the average price target dropping from $5.5 to $4, representing a decline of 27.27%. This adjustment reflects a more conservative outlook despite the price target remaining above the current market price ($1.97), indicating a valuation gap resulting from operational pressures or a reassessment of future risks.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.